genedrive (LON:GDR) Stock Falls 3.3% – Should You Sell?

genedrive plc (LON:GDR) dropped 3.3% on Friday. The company traded as low as GBX 1.15 and last traded at GBX 1.16. Approximately 2,297,968 shares traded hands during trading, a decline of 59% from the average daily volume of 5,539,027 shares. The stock had previously closed at GBX 1.20.

genedrive Stock Down 3.3%

The company has a quick ratio of 5.52, a current ratio of 0.99 and a debt-to-equity ratio of -120.48. The stock has a market cap of £18.62 million, a PE ratio of -1.47 and a beta of 0.97. The business has a 50 day moving average price of GBX 1.23 and a 200 day moving average price of GBX 1.15.

Insider Transactions at genedrive

In related news, insider Gino Miele acquired 700,000 shares of the stock in a transaction on Friday, August 28th. The shares were acquired at an average price of GBX 1 per share, for a total transaction of £7,000. Insiders own 28.09% of the company’s stock.

About genedrive

genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.